Success Story: NIW + EB1A Approved! A Chinese Doctor Overcomes EB1A RFE with Premium Processing Speed

 

Client’s Testimonial:

“This was the most important day of my life. Thank you so much for your professional service.”


On July 24th, 2024, and June 7th, 2025, we received another I-140 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) Approvals for a Doctor in the Field of Hepatology (Approval Notice).


General Field: Hepatology

Position at the Time of Case Filing: Doctor

Country of Origin: China

Country of Residence at the Time of Filing: China

Approval Notice Date: : July 24th, 2024 (NIW); June 7th, 2025 (EB1A)

Processing Time: 1 month, 19 days (NIW); 3 months, 4 days (EB1A) (Premium Processing Requested)


Case Summary:      

We are proud to share the approval of both the National Interest Waiver (NIW) and EB1A petitions for a highly accomplished researcher in hepatology. The NIW petition was approved in July 2024, and the EB1A petition was approved in June 2025 following premium processing and a successful response to a Request for Evidence (RFE). These approvals reflect the petitioner’s significant contributions to improving treatment strategies for liver failure and liver regeneration.

Driving Innovation in Liver Injury and Regenerative Medicine

With a Ph.D. in medical science, the petitioner has established himself as a recognized expert in the fields of liver injury, liver regeneration, and precision therapeutics. His research focuses on the treatment of both acute and chronic liver failure, leveraging novel approaches such as mRNA nanoparticles for targeted drug delivery and macrophage-targeted therapies to mitigate ischemia-reperfusion injury.

Strong Research Record and Growing Influence

At the time of filing, the petitioner had authored:

  • 16 peer-reviewed journal articles, including 4 first-authored and 2 corresponding-authored papers.

These publications had received 388 citations, reflecting widespread recognition of his work within the biomedical and liver research communities. His articles have influenced numerous independent studies focused on liver inflammation, therapeutic development, and immune system modulation.

He has also served as a peer reviewer for at least 42 journals, confirming his stature as a trusted authority in hepatology and liver-targeted therapies.

National Recognition and Funding Support

The petitioner’s research has been funded by prestigious institutions, including the National Key Research and Development Program of China and the National Natural Science Foundation of China (NSFC). These funding sources demonstrate the national and global value placed on his research.

Expert Endorsements Strengthen the Case

The EB1A petition was supported by four letters of recommendation from well-established experts in liver research and biomedical science. These letters highlighted the originality, applicability, and clinical importance of his work.

“His record of success in research, along with his services as a judge for the work of his peers, clearly showcases the immense value and indispensability that his research holds within his field of study.”

Advancing U.S. Health Outcomes through Targeted Liver Therapies

The petitioner’s research directly addresses a growing national and global health burden. By developing more effective therapies for liver failure and leveraging cutting-edge drug delivery platforms, his work aligns closely with U.S. healthcare innovation goals.

We are honored to have supported this exceptional researcher in achieving both NIW and EB1A approvals and look forward to his continued contributions to liver medicine and translational biomedical research.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.


Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)
Category Approval or Refund® Approval or RefilingTM
Approved Sum Success Rate Approved Sum Success Rate
NIW 28,946 99.52% 3,030 98.31%
EB1A 4,322 91.76% 2,870 88.91%
EB1B 793 98.51% 236 90.77%
Total 34,061 98.44% 6,136 93.39%


Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.